Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ENALAPRIL\HYDROCHLOROTHIAZIDE Cause Fall? 54 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 54 reports of Fall have been filed in association with ENALAPRIL\HYDROCHLOROTHIAZIDE. This represents 8.8% of all adverse event reports for ENALAPRIL\HYDROCHLOROTHIAZIDE.

54
Reports of Fall with ENALAPRIL\HYDROCHLOROTHIAZIDE
8.8%
of all ENALAPRIL\HYDROCHLOROTHIAZIDE reports
1
Deaths
23
Hospitalizations

How Dangerous Is Fall From ENALAPRIL\HYDROCHLOROTHIAZIDE?

Of the 54 reports, 1 (1.9%) resulted in death, 23 (42.6%) required hospitalization, and 2 (3.7%) were considered life-threatening.

Is Fall Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ENALAPRIL\HYDROCHLOROTHIAZIDE. However, 54 reports have been filed with the FAERS database.

What Other Side Effects Does ENALAPRIL\HYDROCHLOROTHIAZIDE Cause?

Acute kidney injury (88) Hyponatraemia (81) Dizziness (55) Drug interaction (53) Headache (50) Hypotension (45) Insomnia (45) Drug ineffective (35) Somnolence (34) Fatigue (33)

What Other Drugs Cause Fall?

ADALIMUMAB (11,399) CARBIDOPA\LEVODOPA (7,132) LENALIDOMIDE (6,229) ETANERCEPT (5,839) DALFAMPRIDINE (5,554) APIXABAN (5,063) METHOTREXATE (4,250) DIMETHYL (4,208) TOFACITINIB (4,064) PREGABALIN (4,047)

Which ENALAPRIL\HYDROCHLOROTHIAZIDE Alternatives Have Lower Fall Risk?

ENALAPRIL\HYDROCHLOROTHIAZIDE vs ENALAPRIL\LERCANIDIPINE ENALAPRIL\HYDROCHLOROTHIAZIDE vs ENASIDENIB ENALAPRIL\HYDROCHLOROTHIAZIDE vs ENBREL ENALAPRIL\HYDROCHLOROTHIAZIDE vs ENCORAFENIB ENALAPRIL\HYDROCHLOROTHIAZIDE vs ENDOXAN

Related Pages

ENALAPRIL\HYDROCHLOROTHIAZIDE Full Profile All Fall Reports All Drugs Causing Fall ENALAPRIL\HYDROCHLOROTHIAZIDE Demographics